Long‐Term Clinical Assessment of Combined ACAC HemoperfusionUltrafiltration in Uremia
- 1 May 1979
- journal article
- case report
- Published by Wiley in Artificial Organs
- Vol. 3 (2) , 127-131
- https://doi.org/10.1111/j.1525-1594.1979.tb01024.x
Abstract
ACAC hemoperfusion was used in series with a small fluid removal system for a clinical trial in the treatment of uremia. A 22-month trial included a pretest control period, test period and a post-test control period. The most significant observations from this trial are: 1) the predialysis body weight of the patient could be maintained closer to the patient's dry weight; 2) there was a significant increase in hematocrit; and 3) there was insufficient removal of urea. With the development of an effective urea removal system, a more compact artificial kidney than any presently available will become feasible.Keywords
This publication has 6 references indexed in Scilit:
- Artificial Kidney, Artificial Liver, and Artificial CellsPublished by Springer Nature ,1978
- Formation of amino acid from urea and ammonia by sequential enzyme reaction using a microencapsulated multi-enzyme systemBiochemical and Biophysical Research Communications, 1977
- Clinical Evaluation of the Clearance Profiles of a Portable, Compact, Dialysate-Free System Incorporating Microencafsulated Charcoal Hemoperfusion for Blood Purification with Ultrafiltration for Fluid RemovalJournal of Dialysis, 1977
- Treatment of Severe Fluid Overload by UltrafiltrationNew England Journal of Medicine, 1974
- ACAC MICROCAPSULE ARTIFICIAL KIDNEY FOR THE LONG TERM AND SHORT TERM MANAGEMENT OF ELEVEN PATIENTS WITH CHRONIC RENAL FAILUREAsaio Journal, 1972
- Semipermeable MicrocapsulesScience, 1964